Show/hide main menu

Dr Michael Antoniou

Discoveries and achievements

Principal Discoveries and Achievements

Discovery that transcripts possessing RNA processing (splicing, polyadenylation) defects are arrested at the site of transcription (Custódio et al., 1999). 

Discovery of the first muscle-specific locus control region associated with the human desmin gene locus (Raguz et al., 1998; Tam et al., 2006).

Discovery of ubiquitous chromatin opening elements (UCOEs) associated with the human HNRPA2B1-CBX3 and TBP-PSMB1 housekeeping gene loci (Harland et al., 2002; Antoniou et al., 2003; Williams et al., 2005; Lindahl Allen and Antoniou, 2007; Saunders et al., 2015).

Enhanced establishment of and expression from replication episomal plasmid vectors using the HNRPA2B1-CBX3 UCOE (Hagedorn et al., 2013).  

LCR elements are required for stable, tissue-specific gene expression from within replicating episomal plasmid vectors (Chow et al., 2002).

Biochemistry of splicing-polyadenylation coupling via U2AF65 and CFIm (Antoniou et al., 1998; Millevoi et al., 2002; Millevoi et al., 2006).

Demonstration of efficacy of UCOE expression cassettes within lentiviral vectors (Zhang et al., 2007; Zhang et al., 2010; Pfaff et al., 2013; Dighe et al., 2014).

Development of a clinical grade lentiviral vector for gene therapy of the haemoglobinopathies in clinical trials as of 2015 (Miccio et al., 2008).

Development of bLCR-EF1a based lentiviral vectors for systemic gene therapy of metabolic diseases via red blood cells (Montiel-Equihua et al., 2012) 

Generation of the first primary skeletal myoblast cell model of oculo-pharyngeal muscular dystrophy (OPMD) using desmin LCR expression vectors (Raz et al., 2011).

Discovery that the HNRPA2B1-CBX3 UCOE stabilises expression from tissue-specific promoter/enhancer elements (Talbot et al., 2010; Brendel et al, 2012). 

Development of human desmin promoter-based lentiviral vectors for muscle gene therapy (Talbot et al., 2010; Jonuschies et al., 2014).    

Confirmation using molecular profiling methods that long-term exposure to an ultra-low dose of Roundup (glyphosate-based) herbicide can lead to liver and kidney damage (Mesnage et al., 2015).   

Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454